This independent HPLC-UV/VIS lab test confirms Tirzepatide 30mg from Certified Peptides at >99.80% purity with an actual assay of 27.90 mg. The analysis was performed by Vanguard Laboratory and reported on February 24, 2026, under Lot Number 260218RT403.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. Additional testing confirmed endotoxin levels below 5.00 EU/mg (LAL method), sterility with no growth detected (USP <71>), and non-detectable levels of heavy metals including chromium, arsenic, cadmium, lead, and mercury via ICP-MS.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.